Keywords = Liver fibrosis
| Number of Articles: 86 | ||||
| 26 | Evaluation Effect of Transplanted Mesenchymal Stem Cell on Rat with Liver Cirrhosis | |||
| Volume 14, Issue 1, June 2022, Page 61-79 | ||||
| Amna M. Mostafa; Eman A. Allam; Seham A. Mobarak | ||||
| 27 | Von Willebrand Factor; a New Non-Invasive Marker for Assessment of Liver Fibrosis in Infants and Children | |||
| Volume 87, Issue 1, April 2022, Page 1362-1369 | ||||
| Fawzy Mohamed Abdelrazek; Ahmad Kamal Mansour; Tarek El Sayed Barakat; Nashwa Khairat Abousamra | ||||
| 28 | Comparative Study on The Hepato-Protective Effect of Carvedilol and Nebivolol in Carbon Tetrachloride-Induced Liver Fibrosis in Normotensive and Hypertensive Albino Rats | |||
| Volume 87, Issue 1, April 2022, Page 1116-1124 | ||||
| Ali Foli Abd El-salam; Ahmed M. M. El-Sherbiny; Ali A. El-Salam A. Attia; Ramadan Hassan Ibrahim Thabet; Sherief Motwie Abdelfadeel | ||||
| 29 | Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic Hepatitis C after Directly Acting Antiviral Drugs | |||
| Volume 12, Issue 1, March 2022, Page 92-98 | ||||
| Taha M Hassanin; Hala Ibraheem; Madeha Makhlouf; Waleed Mahmoud; Nadia El-Ameen; Enas Kamal | ||||
| 30 | Comparison between Real-Time Tissue Elastography (HI-RTE) and Fibroscan in Assessment of Liver Fibrosis in Chronic HCV Patients | |||
| Volume 90, Issue 3, March 2022, Page 359-366 | ||||
| IMAN RAMZY, M.D.; HANAN ABDEL HAFEZ, M.D.; MOHAMED EL KASSAS, M.D.; KAMAL HASSAN, M.Sc.; MOHAMED HASSANY, M.D.; AISHA ELSHARKAWY, M.D. | ||||
| 31 | Efficacy of Real-Time Tissue Elastography (HI-RTE) for the Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis C | |||
| Volume 90, Issue 3, March 2022, Page 335-343 | ||||
| IMAN RAMZY, M.D.; HANAN ABDEL HAFEZ, M.D.; MOHAMED EL KASSAS, M.D.; KAMAL HASSAN, M.Sc.; MOHAMED HASSANY, M.D.; AISHA ELSHARKAWY, M.D. | ||||
| 32 | Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non Alcholic Fatty Liver Disease Patients: A Cross-Sectional Study | |||
| Volume 5, Issue 1, January 2022, Page 58-75 | ||||
| Rehab Badawi; Boshra El-sayed Hussein; Mona Mohamed Watany; Hala Moustafa Elsabagh; Walaa Elkhalawany | ||||
| 33 | Invasive and Non-Invasive Evaluation of antifibrotic effect of Losartan on Experimentally Induced Liver Fibrosis: A Biochemical and Histological Study | |||
| Volume 38, Issue 1, January 2022, Page 66-76 | ||||
| Heba M. El-hessy; Noha M Hazem; Dalia M. Saleh; Kamal G. Botros | ||||
| 34 | Histological Effect of Platelet Rich Plasma on CCL4 Induced Liver Fibrosis in Adult Albino Rat | |||
| Volume 44, Issue 4, December 2021, Page 932-940 | ||||
| Faten Abd Elzaher; Manal Hassan Moussa; Mona Hussien Raafat; Maher Mohamed Emara | ||||
| 35 | Metabolomic Profiling of Sansevieria trifasciata hort ex. Prain Leaves and Roots by HPLC-PAD-ESI/MS and its Hepatoprotective Effect via Activation of the NRF2/ARE Signaling Pathway in an Experimentally Induced Liver Fibrosis Rat Model | |||
| Volume 64, Issue 11, November 2021, Page 6647-6671 | ||||
| Mona Raslan; Rehab Abdel Rahman; Hany Fayed; Hanan Ogaly; Rehab Fikry | ||||
| 36 | ASSESSMENT OF LIVER FIBROSIS BEFORE AND AFTER DIRECT ACTING ANTIVIRAL THERAPY IN COMPENSATED HCV RELATED LIVER DISEASE | |||
| Volume 50, Issue 4, October 2021, Page 2927-2936 | ||||
| Ahmed Fathalla Khattab; Islam Ammar; Ahmed Mohamed Massoud | ||||
| 37 | Liver Fibrosis as a Predictive Factor of Response to Pegylated-IFN/ Ribavirin Therapy in Chronic HCV Patients | |||
| Volume 89, September, September 2021, Page 2197-2202 | ||||
| WAHID DOSS, M.D.; MOHAMED ALI SABER, M.D.; MOHAMMAD EL-SAYED, M.D.; AHMED EL DEEB, M.Sc.; GAMAL ESMAT, M.D.* | ||||
| 38 | Autotaxin as a marker for liver fibrosis in chronic HCV patients | |||
| Volume 2, Issue 2, July 2021, Page 142-148 | ||||
| Safaa M Abd Razek; Magda Osman; Zakia A Mohammed; Wafaa El-zefzafy | ||||
| 39 | Biochemical and Histopathological Effects of Colchicine and Moringa oleifera on Thioacetamide-Induced Liver Fibrosis in Rats | |||
| Volume 13, Issue 1, June 2021, Page 265-278 | ||||
| Rasha Tawfike Emara; Nabil Mohamed Taha; Abd El-Wahab Ali Mandour; Mohamed Ali Lebda; Mohamed Abd Albadia Rashed; Medhat Mansour Menshawy | ||||
| 40 | Measurement of plasma microRNA-500 could differentiate between liver fibrosis and cirrhosis | |||
| Volume 5, Issue 2, June 2021, Page 133-142 | ||||
| Nahla El-Ashmawy; Ghada Al-Ashmawy; Linda Zayed; Ayman Hassan; Reham Soliman; Gamal Shiha | ||||
| 41 | Erectile function in patients with Liver fibrosis | |||
| Volume 6, Issue 2, March and April 2021, Page 213-217 | ||||
| A.A. Saleh; G.M. Abdel Khalik; M.A. El Jaky; H.R. Askar | ||||
| 42 | Therapeutic efficacy of Ganoderma Lucidum on Thioacetamide-Induced Hepatic Fibrosis through Inhibition of TGF-β1 signaling in Male Rats. | |||
| Volume 5, Pharmacology-Pharmaceutics, January 2021, Page 1-13 | ||||
| Hanan M. Hassan; Sahar E Elswefy | ||||
| 43 | Aliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression | |||
| Volume 1, Issue 1, January 2021, Page 73-86 | ||||
| Yasmin Hashim; Nayira A Abdel Baky; Mona M Kamal; Amany Gad | ||||
| 44 | Potential therapeutic effects of pomegranate peel on carbon tetrachloride induced liver injury in rat | |||
| Volume 12, Issue 12, December 2020, Page 1-19 | ||||
| هبة ابراهيم غمري | ||||
| 45 | Effect of Successful Direct Acting Antivirals Therapy on Liver Stiffness in Patients with Chronic HCV Infection | |||
| Volume 2, Issue 4, October 2020, Page 854-859 | ||||
| Ibrahim Anam Ezzelregal; Fathya Mostafa Elraie; Khalid Elmola; Mostafa Mohamed Shaqueer | ||||
| 46 | Serum Golgi Protein 73 as a Biomarker for Liver Fibrosis in Chronic Hepatitis C Patients | |||
| Volume 81, Issue 5, October 2020, Page 1993-2000 | ||||
| Hala A Abdel-Azeez; Samar M Sharaf; Eman A Elshamy; Abeer A Fikry | ||||
| 47 | Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni | |||
| Volume 81, Issue 1, October 2020, Page 1275-1280 | ||||
| Tarek K Zaalouk; Gamal A Abo-Sheishaa; Ibrahim R Shalash | ||||
| 48 | PROPOLIS IMPROVED THE HEPATIC ARCHITECTURE BY CONTROLLING STAT-3 AND STAT-5 PHOSPHORYLATION, AND SURVIVIN EXPRESSION IN A MOUSE MODEL OF LIVER FIBROSIS | |||
| Volume 73, Issue 73, June 2020, Page 39-52 | ||||
| Eman Abdo Sayed; Hanan Waly; Khadega A. Hassan; Gamal Badr | ||||
| 49 | The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients | |||
| Volume 10, Issue 2, June 2020, Page 226-232 | ||||
| Ali Nada; Aliaa Sabry; Naglaa S Elabd; Osama Elbahr | ||||
| 50 | Therapeutic Potential of Human Umbilical Cord Blood Derived Mesenchymal Stem Cells in Murine Model of Hepatic Schistosomiasis | |||
| Volume 10, Issue 2, June 2020, Page 151-162 | ||||
| Mohammad Abd-El Rehiem Bebars; Hanan Hussein Kamel; Hala Gabr; Heba Abdel Kader Aminou; Lobna Shash; Shimaa Essam Al-din Mohammed; Ayman Ashkar | ||||
| | ||||
View on SCiNiTO
